Results 161 to 170 of about 111,659 (285)
Abstract Introduction Active surveillance of adverse events using healthcare data is emerging as complementary to the monitoring of spontaneous reports and stand‐alone pharmacoepidemiologic studies. The risk of urinary tract infections (UTIs) was listed as a special warning for sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) when marketed in Europe
Haoxin Le +5 more
wiley +1 more source
Genetic Analysis of Patients With Common Variable Immunodeficiency Followed in the Pulmonology Department: A Report of Five Patients. [PDF]
Boumekrat L +10 more
europepmc +1 more source
Aim Intradermal application of lipopolysaccharide (LPS), a Toll‐like receptor 4 agonist, induces a local inflammatory response and is used as a human challenge model to evaluate the pharmacodynamics of investigational medicinal products. While currently applied in a single, parallel‐group setting, alternative within‐subject designs involving repeated ...
Alexandra A. J. Sillé +12 more
wiley +1 more source
Pulmonary embolism and aseptic meningitis complicating IVIG for common variable immunodeficiency syndrome. [PDF]
Butz D, Adlakha A.
europepmc +1 more source
Common variable immunodeficiency in a 13-year-old Thoroughbred mare
This report describes the clinical progression of a Thoroughbred mare with common variable immunodeficiency (CVID). Equine CVID is a primary immunodeficiency characterized by late-onset B cell lymphopenia or depletion, hypo- or agammaglobulinemia, and ...
Jager, Mason
core
Aim A prior non‐randomized study suggests that potassium supplementation may improve survival among furosemide initiators, and a randomized trial suggests that salt substitutes containing potassium might lower stroke risk. We conducted a retrospective cohort study using health‐care data to confirm or refute these associations among new users of ...
Thanh Phuong Pham Nguyen +8 more
wiley +1 more source
Liver Disease in Common Variable Immunodeficiency: Current Evidence and Knowledge Gaps. [PDF]
Nedelea I +8 more
europepmc +1 more source
Pharmacokinetic profiling of imatinib in relation to CYP3A4 activity in leukaemia patients
Aim Imatinib pharmacokinetics exhibit large interindividual variability because of differences in CYP3A4 activity—the main imatinib‐metabolizing enzyme. While therapeutic drug monitoring is effective, it requires steady‐state conditions and frequent sampling.
Anna Sofie Buhl Rasmussen +14 more
wiley +1 more source
Concurrent hereditary angioedema type I and common variable immunodeficiency presenting as suspected antibiotic hypersensitivity: Case report and literature discussion. [PDF]
Urdea D +3 more
europepmc +1 more source

